CLB — Core Laboratories Income Statement

0.000.00%

Last trade - 00:00

IndustrialsAdventurousMid CapHigh Flyer

Annual income statement for Core Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	PRESS
Standards:	USG	USG	USG	USG	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	470	490	510	524	527
Cost of Revenue
Gross Profit	102	96.1	110	103	109
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	425	448	455	465	470
Operating Profit	45.3	41.5	54.6	58.6	56.5
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	36.1	30	41.2	46.2	45.9
Provision for Income Taxes
Net Income After Taxes	20.2	19.7	37	32.2	32.5
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	19.7	19.5	36.7	31.4	31.8
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	19.7	19.5	36.7	31.4	31.8
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.405	0.447	0.82	0.673	0.676
Dividends per Share